CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 6, 2026
$6,13
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$6,06minimo 52 sett.
$20,56massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$114M
P/E
-1.0
EPS
$-5.90
i tuoi badge
Intervallo 52 sett.
$6–$21
Rating Analisti
BUY
Prezzo Obiettivo
$34
P/E
-1.0
ROE
-60.8%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CRBP Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$6.13
Capitalizzazione di Mercato (MRQ)
$114M
P/E
-1.0
EPS
$-5.90
ROE
-60.8%
Intervallo 52 sett.
$6–$21
CRBP Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 14 Febbraio 2023 | 1-for-30 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi·2016-12-31 → 2022-12-31
EPS$-5.902021-12-31 → 2025-12-31
Flusso di cassa libero$-64M2016-12-31 → 2025-12-31
Margine netto·2016-12-31 → 2021-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CRBP | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -1.0media 5 anni ≈-1.4 | ≈-1.4 | · | · | |
| P/B (MRQ) | 1.1media 5 anni ≈9.0 | ≈9.0 | 1.9 | Sottovalutato | |
| Price / FCF (Prezzo / FCF) | -1.7media 5 anni ≈-16.9 | ≈-16.9 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -1.7media 5 anni ≈-13.5 | ≈-13.5 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.7media 5 anni ≈9.0 | ≈9.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CRBP | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -48.5%media 5 anni ≈-46.1% | ≈-46.1% | -63.2% | Di prim'ordine | |
| ROE | -60.8%media 5 anni ≈-65.9% | ≈-65.9% | -108.3% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CRBP | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 5.7media 5 anni ≈7.9 | ≈7.9 | 5.4 | In linea | |
| Quick Ratio | 7.9media 5 anni ≈7.7 | ≈7.7 | 4.5 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-4.4%
Prossimo report
Nov 10, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 3, 2026 | $-1.81 | $-1.28 | -41.1% |
| 31 Marzo 2026 | $-1.23 | $-1.24 | 1.2% | |
| 31 Dicembre 2025 | $-1.25 | $-1.61 | 22.2% | |
| 30 Settembre 2025 | $-1.90 | $-1.74 | -9.1% | |
| 30 Giugno 2025 | $-1.44 | $-1.54 | 6.6% | |
| 31 Marzo 2025 | $-1.39 | $-1.31 | -6.5% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $881.7K | $4M | $36M | $5M | $2M | $2M | $648.4K | |
| R&D Expense | $70M | $32M | $31M | $16M | $36M | $98M | $90M | $49M | $26M | $15M | $6M | |
| SG&A Expense | $15M | $16M | $14M | $19M | $20M | $28M | $24M | $13M | $9M | $6M | $4M | |
| Operating Expenses | $85M | $49M | $45M | $40M | $57M | $127M | $113M | $62M | $35M | $22M | $10M | |
| Operating Income | $-85M | $-49M | $-45M | $-40M | $-56M | $-123M | $-77M | $-57M | $-33M | $-20M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $2.4K | |
| Interest Income | · | · | · | · | · | · | $1M | $982.8K | · | · | $3.4K | |
| Other Non-op | $1M | $4M | $3M | $-48.8K | $12M | $13M | $6M | $1M | $141.2K | $-13.6K | $3.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Income | $-79M | $-40M | $-45M | $-42M | $-46M | $-111M | $-71M | $-56M | $-32M | $-20M | $-9M | |
| EPS (Basic) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | $-1.42 | · | · | · | · | · | |
| EPS (Diluted) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | · | · | · | · | · | · | |
| Shares (Basic) | 13,317,116 | 10,915,413 | 4,327,568 | 4,170,675 | 4,094,935 | 78,133,289 | · | · | · | · | · | |
| Shares (Diluted) | 13,317,116 | 10,915,413 | 4,327,568 | 4,170,675 | 4,094,935 | · | · | · | · | · | · | |
| EBITDA | $-85M | $-49M | · | $-40M | $-56M | $-123M | $-77M | $-57M | $-33M | $-20M | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $17M | $14M | $17M | $25M | $85M | $32M | $42M | $63M | $15M | $12M | |
| Short-term Investments | $135M | $132M | $7M | $42M | $73M | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $4M | $2M | $791.6K | $2M | $4M | $4M | $2M | $3M | $930.3K | $376.5K | |
| Current Assets | $167M | $153M | $24M | $60M | $100M | $92M | $38M | $44M | $66M | $17M | $13M | |
| PP&E (Net) | $159.0K | $385.0K | $973.0K | $2M | $2M | $4M | $5M | $3M | $1M | $435.3K | $124.1K | |
| PP&E (Gross) | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $3M | $2M | $543.5K | $178.5K | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $2M | $2M | $1M | $666.6K | $363.9K | $108.2K | $54.3K | |
| Other Non-current Assets | · | $0 | $212.0K | $155.3K | $46.4K | $234.0K | $85.0K | $43.8K | $40.8K | · | · | |
| Total Assets | $168M | $156M | $28M | $66M | $108M | $102M | $49M | $47M | $67M | $18M | $13M | |
| Accounts Payable | $2M | $5M | $3M | $2M | $2M | $7M | $11M | $6M | $3M | $3M | $1M | |
| Accrued Liabilities | $17M | $5M | $11M | $6M | $10M | $22M | $22M | $10M | $5M | $3M | $562.3K | |
| Short-term Debt | · | $0 | $301.0K | $353.3K | $767.9K | $710.2K | $752.7K | $394.3K | $332.9K | $271.8K | $162.0K | |
| Current Liabilities | $21M | $12M | $32M | $13M | $17M | $32M | $35M | $18M | $8M | $9M | $4M | |
| Capital Leases | $0 | $2M | $3M | $5M | $6M | $7M | $8M | · | · | · | · | |
| Other Non-current Liabilities | · | $0 | $44.0K | $22.2K | $22.2K | · | · | · | $375 | $4.6K | · | |
| Total Liabilities | $21M | $13M | $35M | $33M | $39M | $57M | $43M | $19M | $9M | $9M | $4M | |
| Long-term Debt | · | · | $18M | $22M | $21M | $21M | · | · | · | · | · | |
| Total Debt | · | $0 | · | $19M | $19M | $19M | $752.7K | $394.3K | $332.9K | $271.8K | $162.0K | |
| Common Stock | $2.0K | $1.0K | $0 | $417 | $416 | $9.9K | $6.5K | $5.7K | $5.6K | $4.5K | $3.8K | |
| Paid-in Capital | $703M | $619M | $430M | $425M | $419M | $349M | $199M | $149M | · | · | · | |
| Retained Earnings | $-555M | $-477M | $-437M | $-392M | $-350M | $-304M | $-193M | $-121M | $-66M | $-33M | $-13M | |
| AOCI | $-53.0K | $35.0K | $-1.0K | $-126.1K | $-62.4K | · | · | · | · | · | · | |
| Stockholders' Equity | $148M | $142M | $-7M | $33M | $69M | $45M | $6M | $28M | $58M | $9M | $9M | |
| Liabilities + Equity | $168M | $156M | $28M | $66M | $108M | $102M | $49M | $47M | $67M | $18M | $13M | |
| Shares Outstanding | 17,611,511 | 12,179,482 | 4,423,683 | 4,171,297 | 4,169,631 | 98,852,696 | 64,672,893 | 57,247,496 | 55,603,427 | 44,681,745 | 37,605,134 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $233.0K | $588.0K | $641.0K | $763.0K | $999.8K | $1M | $739.4K | $493.9K | $255.7K | $87.7K | $43.9K | |
| Stock-based Comp | $6M | $6M | $3M | $6M | $9M | $12M | $12M | $8M | $6M | $3M | $1M | |
| Operating Cash Flow | $-64M | $-42M | $-36M | $-38M | $-48M | $-100M | $-46M | $-30M | $-28M | $-14M | $-5M | |
| CapEx | $7.0K | $0 | $0 | $13.4K | $54.2K | $484.5K | $3M | $2M | $707.4K | $353.0K | $114.0K | |
| Investing Cash Flow | $-2M | $-121M | $36M | $30M | $-73M | $-484.5K | $-3M | $-2M | $-707.4K | · | · | |
| Debt Issued | · | · | · | $1M | · | $19M | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $1M | · | $19M | · | · | · | · | · | |
| Stock Issued | $77M | $182M | $53.0K | · | $63M | $142M | $41M | $12M | $79M | $17M | $11M | |
| Net Stock Activity | $77M | $182M | · | · | $63M | $142M | $41M | $12M | $79M | $17M | $11M | |
| Financing Cash Flow | $77M | $167M | $-3M | $-533.6K | $61M | $155M | $38M | $11M | $76M | · | · | |
| Net Change in Cash | $11M | $3M | $-3M | $-8M | $-61M | $55M | $-10M | $-21M | $48M | · | $6M | |
| Free Cash Flow | $-64M | · | · | $-38M | $-48M | $-100M | $-48M | $-32M | $-29M | $-14M | $-5M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% | -1365.5% | |
| Net Margin | · | · | · | · | -5176.4% | -2826.1% | -197.7% | -1154.5% | -1328.7% | -1046.3% | -1365.0% | |
| EBITDA Margin | · | · | · | · | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% | -1365.5% | |
| ROA | -48.5% | -43.7% | · | -48.7% | -43.5% | -146.9% | -148.7% | -97.7% | -76.4% | -130.0% | -90.9% | |
| ROE | -60.8% | -27.5% | · | -113.0% | -62.2% | -298.7% | -399.2% | -158.2% | -97.2% | -223.4% | -119.2% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 12.9 | · | 4.8 | 5.9 | 2.9 | 1.1 | 2.4 | 8.0 | 2.0 | 3.5 | |
| Quick Ratio | 7.9 | 12.6 | · | 4.7 | 5.7 | 2.7 | 0.9 | 2.3 | 7.6 | 1.7 | 3.4 | |
| Debt / Equity | · | 0.0 | · | 0.6 | 0.3 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | 0.5 | 0.2 | 0.4 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -3628.6 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.1 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.38 | $11.69 | · | $7.91 | $0.55 | $0.46 | $0.10 | $0.48 | $1.04 | $0.20 | $0.24 | |
| Revenue / Share | · | · | · | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-4.84 | $-3.83 | · | $-9.00 | · | · | · | · | · | · | · | |
| Cash / Share | $1.62 | $1.41 | · | $4.08 | $0.20 | $0.86 | $0.49 | $0.73 | $1.12 | $0.34 | $0.33 | |
| EPS (TTM) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | -77.6% | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $0 | $881.7K | $4M | $36M | $5M | $2M | $2M | $648.4K | |
| Net Income TTM | $-79M | $-40M | $-45M | $-42M | $-46M | $-111M | $-71M | $-56M | $-32M | $-20M | $-9M | |
| Market Cap | $143M | $144M | · | $14M | $2.31B | $3.71B | $10.59B | $10.03B | $11.84B | $11.33B | $1.86B | |
| Enterprise Value | · | $-5M | · | $-26M | $2.24B | $3.64B | $10.56B | $9.99B | $11.78B | $11.31B | $1.85B | |
| P/E | -1.4 | -3.2 | -0.6 | -0.3 | -1.7 | · | · | · | · | · | · | |
| P/S | · | · | · | · | 2624.8 | 941.5 | 293.1 | 2079.9 | 4853.5 | 5925.9 | 2870.9 | |
| P/B | 1.0 | 1.0 | · | 0.4 | 33.5 | 81.9 | 1720.4 | 364.4 | 205.0 | 1269.9 | 207.2 | |
| P / Tangible Book | 1.0 | 1.0 | · | 0.4 | 33.5 | 81.9 | · | · | · | · | · | |
| P / Cash Flow | -2.2 | -3.4 | · | -0.4 | -48.0 | -37.2 | -231.7 | -333.6 | -426.1 | -834.6 | -400.5 | |
| P / FCF | -2.2 | · | · | -0.4 | -48.0 | -37.0 | -218.6 | -309.9 | -415.5 | -813.5 | -390.9 | |
| EV / EBITDA | · | 0.1 | · | 0.7 | -39.9 | -29.6 | -137.0 | -176.0 | -361.8 | -566.0 | -208.9 | |
| EV / FCF | · | · | · | 0.7 | -46.4 | -36.3 | -217.9 | -308.6 | -413.3 | -812.4 | -388.4 | |
| EV / Revenue | · | · | · | · | 2536.1 | 924.6 | 292.2 | 2071.3 | 4828.0 | 5918.2 | 2852.1 | |
| Earnings Yield | -72.5% | -31.2% | -170.7% | -304.8% | -60.3% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $31M | $20M | $18M | $21M | $15M | $16M | $9M | $11M | $7M | $6M | $7M | $7M | $4M | $13M | $6M | $4M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $3M | $4M | $4M | $5M | $4M | |
| Operating Expenses | $36M | $24M | $22M | $24M | $19M | $20M | $13M | $16M | $11M | $10M | $10M | $9M | $8M | $17M | $11M | $8M | |
| Operating Income | $-36M | $-24M | $-22M | $-24M | $-19M | $-20M | $-13M | $-16M | $-11M | $-10M | $-10M | $-9M | $-8M | $-17M | $-11M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $652.0K | · | · | · | $1M | · | · | · | |
| Other Non-op | $-11.0K | $-67.0K | $1.0K | $-50.0K | $176.0K | $1M | $1M | $200.0K | $43.0K | $3M | $2M | $218.0K | $183.0K | $229.5K | $275.5K | $77.7K | |
| Net Income | $-35M | $-23M | $-21M | $-23M | $-18M | $-17M | $-10M | $-14M | $-10M | $-7M | $-8M | $-10M | $-9M | $-18M | $-11M | $-9M | |
| EPS (Basic) | $-1.81 | $-1.23 | $-1.17 | $-1.90 | $-1.44 | $-1.39 | $-0.80 | $-1.15 | $-0.90 | $-0.83 | $-1.75 | $-2.27 | $-2.05 | $-4.24 | $-2.60 | $-2.11 | |
| EPS (Diluted) | $-1.81 | $-1.23 | $-1.17 | $-1.90 | $-1.44 | $-1.39 | $-0.80 | $-1.15 | $-0.90 | $-0.83 | $-1.75 | $-2.27 | $-2.05 | $-4.24 | $-2.60 | $-2.11 | |
| Shares (Basic) | 19,407,688 | 18,706,622 | · | 12,307,298 | 12,240,443 | 12,202,092 | · | 12,014,700 | 11,053,241 | 8,310,508 | · | 4,423,617 | 4,277,701 | 4,181,556 | · | 4,170,881 | |
| Shares (Diluted) | 19,407,688 | 18,706,622 | · | 12,307,298 | 12,240,443 | 12,202,092 | · | 12,014,700 | 11,053,241 | 8,310,508 | · | 4,423,617 | 4,277,701 | 4,181,556 | · | 4,170,881 | |
| EBITDA | $-36M | $-24M | · | $-24M | $-19M | $-20M | · | $-16M | $-11M | $-10M | · | $-9M | $-8M | $-17M | · | $-8M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $26M | $28M | $27M | $20M | $19M | $17M | $19M | $24M | $14M | $14M | $11M | $8M | $7M | $17M | $12M | |
| Short-term Investments | $95M | $113M | $135M | $77M | $97M | $114M | $132M | $140M | $123M | $106M | $7M | $17M | $28M | $37M | $42M | $54M | |
| Prepaid Expense | $5M | $5M | $3M | $3M | $6M | $4M | $4M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $791.6K | $926.2K | |
| Current Assets | $123M | $144M | $167M | $108M | $123M | $137M | $153M | $161M | $148M | $122M | $24M | $31M | $38M | $46M | $60M | $67M | |
| PP&E (Net) | $71.0K | $116.0K | $159.0K | $201.0K | $251.0K | $304.0K | $385.0K | $519.0K | $671.0K | $821.5K | $973.0K | $1M | $1M | $1M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $0 | $0 | $212.0K | $201.3K | $211.9K | $182.4K | $155.3K | $133.1K | |
| Total Assets | $127M | $144M | $168M | $110M | $125M | $140M | $156M | $164M | $152M | $126M | $28M | $36M | $44M | $52M | $66M | $74M | |
| Accounts Payable | $5M | $435.0K | $2M | $3M | $4M | $4M | $5M | $3M | $1M | $2M | $3M | $5M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $15M | $16M | $17M | $13M | $8M | $6M | $5M | $7M | $10M | $9M | $11M | $8M | $6M | $6M | $6M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $77.0K | $189.8K | $301.0K | $0 | $51.2K | $203.3K | $353.3K | $0 | |
| Current Liabilities | $21M | $18M | $21M | $17M | $13M | $12M | $12M | $12M | $24M | $26M | $32M | $32M | $16M | $14M | $13M | $17M | |
| Capital Leases | $3M | · | $0 | $307.0K | $761.0K | $1M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $44.0K | $44.4K | $22.2K | $3M | $22.2K | $22.2K | |
| Total Liabilities | $25M | $18M | $21M | $17M | $14M | $13M | $13M | $14M | $26M | $29M | $35M | $36M | $34M | $35M | $33M | $32M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $13M | · | $20M | $21M | $22M | $19M | $21M | |
| Total Debt | · | · | · | · | · | · | · | $0 | $77.0K | $13M | · | $18M | $18M | $19M | · | $19M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.1K | $0 | $442 | $442 | $422 | $417 | $12.5K | |
| Paid-in Capital | $716M | $705M | $703M | $627M | $623M | $621M | $619M | $618M | $580M | $541M | $430M | $429M | $428M | $426M | $425M | $423M | |
| Retained Earnings | $-613M | $-578M | $-555M | $-535M | $-512M | $-494M | $-477M | $-467M | $-454M | $-444M | $-437M | $-429M | $-419M | $-410M | $-392M | $-381M | |
| AOCI | $-107.0K | $-161.0K | $-53.0K | $-3.0K | $-39.0K | $-23.0K | $35.0K | $207.0K | $-388.0K | $-328.5K | $-1.0K | $-8.0K | $-23.8K | $-68.5K | $-126.1K | $-206.9K | |
| Stockholders' Equity | $102M | $126M | $148M | $92M | $111M | $127M | $142M | $150M | $126M | $97M | $-7M | $311.0K | $10M | $16M | $33M | $42M | |
| Liabilities + Equity | $127M | $144M | $168M | $110M | $125M | $140M | $156M | $164M | $152M | $126M | $28M | $36M | $44M | $52M | $66M | $74M | |
| Shares Outstanding | 18,671,498 | 17,738,870 | 17,611,511 | 12,534,853 | 12,254,069 | 12,232,853 | 12,179,482 | 12,179,482 | 11,498,917 | 10,507,237 | 4,423,683 | 4,423,683 | 4,422,741 | 4,215,133 | 4,171,297 | 125,280,881 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $51.0K | $49.0K | $49.0K | $50.0K | $53.0K | $81.0K | $134.0K | $152.0K | $150.3K | $152.0K | $148.0K | $152.8K | $158.1K | $181.9K | $184.4K | $190.8K | |
| Stock-based Comp | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $982.0K | $799.0K | $821.2K | $823.6K | $1M | $1M | $1M | |
| Operating Cash Flow | $-30M | $-26M | $-16M | $-16M | $-17M | $-16M | $-11M | $-14M | $-9M | $-8M | $-6M | $-7M | $-8M | $-15M | $-7M | $-7M | |
| CapEx | $6.0K | $6.0K | · | · | $0 | $0 | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $18M | $22M | $-57M | $20M | $18M | $18M | $9M | $-15M | $-16M | $-98M | $10M | $11M | $9M | $6M | $12M | $-6M | |
| Stock Issued | · | · | $75M | $3M | $0 | $0 | $-13.0K | $36M | $31M | $109M | $-74.0K | $-109.6K | $169.9K | $37.1K | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $116M | · | · | · | $37.1K | · | · | |
| Financing Cash Flow | · | · | $75M | $3M | $0 | $0 | $-13.0K | $25M | $35M | $107M | $-2M | $-820.7K | $18.0K | $-113.0K | $234.3K | $-110.7K | |
| Net Change in Cash | $-2M | $-3M | $2M | $7M | $1M | $2M | $-2M | $-4M | $10M | $379.0K | $2M | $3M | $1M | $-10M | $5M | $-13M | |
| Free Cash Flow | · | $-26M | · | · | · | · | · | · | · | · | · | · | · | $-15M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -1304.0% | -1212.8% | 5436.1% | · | 1242.9% | 1055.9% | 2551.1% | · | · | |
| Net Margin | · | · | · | · | · | · | · | -1159.2% | -1103.4% | 3897.3% | · | 1317.0% | 1132.5% | 2617.1% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -1304.0% | -1212.8% | 5436.1% | · | 1242.9% | 1055.9% | 2551.1% | · | · | |
| ROA | -27.8% | -16.2% | · | -17.1% | -12.8% | -12.8% | · | -13.8% | -10.2% | -7.8% | · | -18.3% | -14.0% | -24.1% | · | -9.1% | |
| ROE | -32.9% | -18.1% | · | -19.2% | -14.9% | -15.2% | · | -18.3% | -14.8% | -12.2% | · | -47.6% | -29.8% | -45.7% | · | -14.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.9 | · | 6.3 | 9.2 | 11.8 | · | 13.8 | 6.2 | 4.7 | · | 1.0 | 2.3 | 3.2 | · | 3.9 | |
| Quick Ratio | 5.5 | 7.6 | · | 6.1 | 8.7 | 11.4 | · | 13.7 | 6.1 | 4.6 | · | 0.9 | 2.2 | 3.1 | · | 3.8 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · | 57.4 | 1.9 | 1.2 | · | 0.5 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | 1.2 | 0.8 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -16.9 | · | · | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.48 | $7.12 | · | $7.35 | $9.06 | $10.39 | · | $12.36 | $10.92 | $9.23 | · | $0.07 | $2.15 | $3.90 | · | $0.33 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.10 | $0.08 | $-0.02 | · | $-0.17 | $-0.18 | $-0.16 | · | $0.00 | |
| Cash Flow / Share | · | $-1.37 | · | · | · | $-1.35 | · | · | · | $-0.96 | · | · | · | $-3.61 | · | · | |
| Cash / Share | $1.25 | $1.45 | · | $2.15 | $1.64 | $1.54 | · | $1.59 | $2.06 | $1.34 | · | $2.54 | $1.89 | $1.74 | · | $0.10 | |
| EPS (TTM) | $-6.11 | $-5.74 | · | $-5.53 | $-4.78 | $-4.24 | · | $-4.63 | $-5.75 | $-6.90 | · | $-11.16 | $-11.00 | $-12.13 | · | $-18.41 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-102M | $-85M | · | $-68M | $-58M | $-50M | · | $-39M | $-35M | $-34M | · | $-47M | $-46M | $-51M | · | $-42M | |
| Market Cap | $175M | $167M | · | $159M | $85M | $65M | · | $251M | $520M | $412M | · | $30M | $35M | $31M | · | $620M | |
| Enterprise Value | · | · | · | · | · | · | · | $92M | $373M | $305M | · | $19M | $16M | $6M | · | $573M | |
| P/E | -1.5 | -1.6 | · | -2.3 | -1.4 | -1.3 | · | -4.5 | -7.9 | -5.7 | · | -0.6 | -0.7 | -0.6 | · | -0.3 | |
| P/B | 1.7 | 1.3 | · | 1.7 | 0.8 | 0.5 | · | 1.7 | 4.1 | 4.3 | · | 95.9 | 3.6 | 1.9 | · | 14.8 | |
| P / Tangible Book | 1.7 | 1.3 | · | 1.7 | 0.8 | 0.5 | · | 1.7 | 4.1 | 4.3 | · | 95.9 | 3.6 | 1.9 | · | 14.8 | |
| P / Cash Flow | · | -6.5 | · | · | · | -4.0 | · | · | · | -51.7 | · | · | · | -2.0 | · | · | |
| Earnings Yield | -65.1% | -61.1% | · | -43.7% | -69.3% | -79.8% | · | -22.4% | -12.7% | -17.6% | · | -165.6% | -140.3% | -166.9% | · | -371.9% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | · | · | · | $0 | $881.7K |
| Margine Operativo % | · | · | · | · | -6350.1% |
| Utile netto | $-79M | $-40M | $-45M | $-42M | $-46M |
| EPS Diluito | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | 0.0 | · | 0.6 | 0.3 |
| Rapporto corrente | 8.1 | 12.9 | · | 4.8 | 5.9 |
| Quick Ratio | 7.9 | 12.6 | · | 4.7 | 5.7 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-64M | · | · | $-38M | $-48M |
Proprietari istituzionali (13F) 124 filer · $154.4M totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
124
Valore detenuto
$154.4M
Nuove posizioni
26
Posizioni chiuse
23
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 26 (-7 vs trimestre precedente) | 23 (+11 vs trimestre precedente) | 35 (+1 vs trimestre precedente) | 27 (+5 vs trimestre precedente) | +2.3M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Cormorant Asset Management, LP | $21.995.828 | 2.344.971 | 14,25% | Azioni |
| ORBIMED ADVISORS LLC | $16.295.752 | 1.737.287 | 10,56% | Azioni |
| BlackRock, Inc. | $12.486.047 | 1.331.135 | 8,09% | Azioni |
| Aberdeen Group plc | $12.398.015 | 1.321.750 | 8,03% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.137.617 | 760.940 | 4,62% | Azioni |
| VANGUARD GROUP INC | $6.995.573 | 859.407 | 4,53% | Azioni |
| Jones Hill Capital LP | $6.130.505 | 653.572 | 3,97% | Azioni |
| Prosight Management, LP | $6.097.000 | 650.000 | 3,95% | Azioni |
| DIADEMA PARTNERS LP | $5.945.044 | 633.800 | 3,85% | Opzione Call |
| Caption Management, LLC | $5.368.174 | 572.300 | 3,48% | Opzione Call |
| Stonepine Capital Management, LLC | $3.986.500 | 425.000 | 2,58% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $3.972.122 | 423.374 | 2,57% | Azioni |
| ADAR1 Capital Management, LLC | $3.956.362 | 421.787 | 2,56% | Azioni |
| DIADEMA PARTNERS LP | $2.825.856 | 301.264 | 1,83% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.750.244 | 293.203 | 1,78% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.511.964 | 267.800 | 1,63% | Opzione Call |
| STATE STREET CORP | $2.388.823 | 254.672 | 1,55% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $1.783.533 | 190.214 | 1,16% | Azioni |
| Exome Asset Management LLC | $1.734.493 | 184.914 | 1,12% | Azioni |
| COMERICA BANK | $1.628.008 | 200.001 | 1,05% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.422.383 | 151.640 | 0,92% | Azioni |
| JANE STREET GROUP, LLC | $1.305.068 | 139.133 | 0,85% | Azioni |
| NORTHERN TRUST CORP | $1.171.618 | 124.906 | 0,76% | Azioni |
| CITADEL ADVISORS LLC | $1.071.196 | 114.200 | 0,69% | Opzione Call |
| VANGUARD FIDUCIARY TRUST CO | $1.054.284 | 112.397 | 0,68% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.044.013 | 111.302 | 0,68% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.039.510 | 110.822 | 0,67% | Azioni |
| DAFNA Capital Management LLC | $1.010.911 | 107.773 | 0,65% | Azioni |
| CITADEL ADVISORS LLC | $864.405 | 92.154 | 0,56% | Azioni |
| Advisory Services Network, LLC | $843.740 | 89.951 | 0,55% | Azioni |
| MARSHALL WACE, LLP | $744.125 | 79.331 | 0,48% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $732.766 | 78.120 | 0,47% | Azioni |
| Persistent Asset Partners Ltd | $721.500 | 76.919 | 0,47% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $712.683 | 75.979 | 0,46% | Azioni |
| XTX Topco Ltd | $634.595 | 67.654 | 0,41% | Azioni |
| Verdad Advisers, LP | $596.596 | 63.603 | 0,39% | Azioni |
| GOLDMAN SACHS GROUP INC | $589.655 | 62.863 | 0,38% | Azioni |
| ADAR1 Capital Management, LLC | $562.800 | 60.000 | 0,36% | Opzione Call |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $520.168 | 55.455 | 0,34% | Azioni |
| DOLIVER ADVISORS, LP | $518.149 | 75.975 | 0,34% | Azioni |
| HSBC HOLDINGS PLC | $504.747 | 55.224 | 0,33% | Azioni |
| UBS Group AG | $457.716 | 48.797 | 0,30% | Azioni |
| Bank of New York Mellon Corp | $424.746 | 45.282 | 0,28% | Azioni |
| Rangeley Capital, LLC | $412.720 | 44.000 | 0,27% | Azioni |
| CANTOR FITZGERALD, L. P. | $376.117 | 40.098 | 0,24% | Azioni |
| Driehaus Capital Management LLC | $365.604 | 38.977 | 0,24% | Azioni |
| LMR Partners LLP | $332.990 | 35.500 | 0,22% | Azioni |
| Engineers Gate Manager LP | $279.524 | 29.800 | 0,18% | Azioni |
| Caption Management, LLC | $261.252 | 27.852 | 0,17% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $250.446 | 26.700 | 0,16% | Opzione Put |
Insider aziendali 25 insider · 7 dirigenti · 13 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark Tepper | President and CSO | 18 Gennaio 2019 A | 2.110.400 | 0 | 0 | $0 |
| Ian Hodgson | Chief Operating Officer | 17 Febbraio 2026 S | 51.080 | 0 | 2 | $-25.788 |
| Craig Stuart Millian | Chief Operating Officer | 13 Febbraio 2023 A | 27.000 | 0 | 0 | $0 |
| Robert Paul Discordia | Chief Operating Officer | 17 Marzo 2020 P | 35.490 | 0 | 0 | $0 |
| Dominic Smethurst | Chief Medical Officer | 02 Marzo 2026 S | 89.790 | 0 | 2 | $-77.181 |
| Rachael Louise Brake | Chief Scientific Officer | 13 Febbraio 2023 A | · | 0 | 0 | $0 |
| Barbara White | Chief Medical Officer | 02 Febbraio 2021 A | 206.217 | 0 | 0 | $0 |
| Yong Ben | Direttore | 14 Settembre 2026 S | 9.383 | 0 | 1 | $-15.680 |
| Anne Altmeyer | Direttore | 10 Giugno 2026 S | 7.579 | 0 | 2 | $-40.809 |
| John Kenneth Jenkins | Direttore | 10 Giugno 2026 S | 3.833 | 0 | 1 | $-37.968 |
| Winston Kung | Direttore | 10 Giugno 2026 S | 12.140 | 0 | 1 | $-16.026 |
| Brent Pfeiffenberger | Direttore | 19 Maggio 2026 A | 7.500 | 0 | 0 | $0 |
| Rachelle Suzanne Jacques | Direttore | 19 Maggio 2026 A | 11.383 | 0 | 0 | $0 |
| Alan F Holmer | Direttore | 30 Maggio 2025 A | 10.629 | 0 | 0 | $0 |
| Peter Salzmann | Direttore | 30 Maggio 2024 A | 2.783 | 0 | 0 | $0 |
| Avery W Catlin | Direttore | 30 Maggio 2024 A | 4.350 | 0 | 0 | $0 |
| George Golumbeski | Direttore | 06 Luglio 2020 A | · | 0 | 0 | $0 |
| David P Hochman | Direttore | 20 Maggio 2020 A | 7.000 | 0 | 0 | $0 |
| Paris Panayiotopoulos | Direttore | 22 Maggio 2019 A | 14.285 | 0 | 0 | $0 |
| Renu Gupta | Direttore | 25 Maggio 2017 A | 15.000 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | · | 16 Agosto 2026 A | 58.333 | 0 | 0 | $0 |
| Nishant C Saxena | · | 11 Agosto 2026 P | 77.900 | 3 | 0 | $126.243 |
| Yuval Cohen | · | 07 Agosto 2026 S | 157.316 | 0 | 4 | $-750.480 |
| Sean F. Moran | · | 07 Agosto 2026 S | 84.694 | 0 | 3 | $-378.471 |
| Sumner Burstein | · | 16 Novembre 2015 G | 3.594.471 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 14 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 56.554 SH | 11 Settembre 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14.313 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 7.862 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 421.328 SH | 11 Settembre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 58.383 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.791 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 201 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 2.680 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 4.229 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 208.310 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 533.575 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 95.158 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.831 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 156.222 SH | 11 Settembre 2026 | Giornaliero |
CRBP Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 16 analisti
COMPRA
Target mediano
$34.00
+454,6%
7 43,8%
Acquisto forte
8 50,0%
Compra
1 6,2%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
10 analisti · 2026-09-30Target medio $34.02 +455,1%
← Sotto tutti i target
Prezzo attuale $6.13
Basso$17.25
Media$34.02
Alto$48.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026